Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center
单中心254例阑尾源性腹膜假性黏液瘤细胞减灭术联合腹腔温热化疗围手术期安全性分析
作者: Xin-Bao LiRu MaZhong-He JiYu-Lin LinJue ZhangZhi-Ran YangLin-Feng ChenFeng-Cai YanYan Li
作者单位: 1Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, PR China
2Department of Blood Transfusion, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, PR China
3Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, PR China
刊名: European Journal of Surgical Oncology, 2020, Vol.46 (4), pp.600-606
来源数据库: Elsevier Journal
DOI: 10.1016/j.ejso.2020.01.017
关键词: Cytoreductive surgeryHyperthermic intraperitoneal chemotherapyPseudomyxoma peritoneiSerious adverse events
英文摘要: Abstract(#br)Objective(#br)Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a standard treatment for pseudomyxoma peritonei (PMP) recommended by Peritoneal Surface Oncology Group International (PSOGI). The study is to analyze the incidence of perioperative serious adverse events (SAEs) of CRS + HIPEC to treat PMP patients, and identify the risk factors, for guiding the prevention of SAEs.(#br)Methods(#br)This is a retrospective study on the PMP database established at our center. The clinicopathological features, treatment details and SAEs information on the PMP patients are systematically established in this database. The incidence, organ system distribution and severity of perioperative SAEs are analyzed. Univariate and multivariate analyses are...
全文获取路径: Elsevier  (合作)
分享到:
来源刊物:
影响因子:2.614 (2012)

×
关键词翻译
关键词翻译
  • pseudomyxoma 假粘液瘤
  • chemotherapy 化学疗法
  • appendiceal 阑尾的
  • safety 安全
  • center 中心
  • surgery 外科
  • after 在之后
  • origin 起原
  • single 单独的